在儿童发烧发作后发生二次的危险因素:元分析
Jing Zhang1, Qiaomei Jing2, Shangbin Li2
1Department of Neurology, First Affifiliated Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang 050000, China.
Epilepsy & behavior : E&B
|September 22, 2024
概括
在患有发烧性 (FS) 的儿童中发现二次性的危险因素至关重要. 过早分娩,围产性窒息,早期发作和异常的EEG/成像是FS后发展的关键危险因素.
科学领域:
- 儿科神经学 儿科神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床遗传学 临床遗传学
背景情况:
- 发烧性发作 (FS) 在儿童中很常见.
- 一部分患有FS的儿童患有.
- 早期识别风险因素对于干预至关重要.
研究的目的:
- 系统地评估发烧的儿童中二次的危险因素.
- 为及时的临床干预和改善预后提供基础.
主要方法:
- 在多个数据库 (PubMed,Embase,Web of Science等) 进行全面的文献搜索. 在2023年10月之前.
- 对23项涉及714例病例和5269例对照研究的元分析.
- 使用Stata 15.0.0.进行的统计分析.
主要成果:
- 确定的重大风险因素包括早产,围产窒息,第一次发作的早期年龄 (<12个月),低峰温度 (<39°C) 和发烧后发作的快速发作.
- 复杂发烧发作 (FS),持续时间长 (>15分钟),多次发作,焦点发作,复发FS (≥2),神经发育异常和发育迟缓与风险增加有关.
- 或FS的家族病史,电脑电图 (EEG) 异常和脑成像异常也是显著的危险因素.
结论:
- 这一元分析系统地确定了儿童发烧性后出现二次性的关键风险因素.
- 干预策略应针对可修改的风险因素.
- 高风险儿童,无论可改变的因素,都需要早期检测和持续跟踪以减轻风险.
更多相关视频
相关概念视频
01:13Seizures: Classification
307
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
307
01:24Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
01:14Antiepileptic Drugs: Glutamate Antagonists
292
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
292
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
341
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341
01:22Methods of reducing fever
645
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
645